DiaSorin
Streck Quality Controls for DiaSorin's Luminex Sepsis Tests Receive FDA Clearance
The quality controls are designed to verify the performance of the Luminex Verigene Blood Culture Gram-Positive and Gram-Negative tests.
Decline in DiaSorin's Q2 MDx Revenues Offset by Strength in Immunodiagnostics
Non-COVID-19 immunodiagnostics revenues drove an otherwise strong quarter for DiaSorin with continued growth in North America and Europe and slow improvement in China.
The company received 510(k) clearance to run the test in whole-blood samples, making it more accessible to settings like urgent care facilities.
DiaSorin Nabs CE Marking for Legionella Immunoassay
The firm said it will sell its Liaison Legionella Urinary Antigen Immunodiagnostic Assay in all countries that accept the CE mark.
Top Five Articles on 360Dx Last Week: Biocartis Reorganizing; CDC's New Training Program; and More
Last week, readers were most interested in a story about layoffs at Biocartis as part of a plan to save €18 million in annual operating expenses.